CSE:ACOG - Post Discussion
Post by
culturedpiggy01 on Feb 15, 2022 5:45pm
$ACOG.v CEO talks neurodegenerative diseases and treatments
$ACOG.v ‘s CEO Michael McFadden joined the folks at OTC markets for their OTCQB podcast where he breaks down the types of neurodegenerative diseases that are targeted in $ACOG ‘s developing treatments and programshttps://www.otcmarkets.com/podcast/otcqb/episodes/3685f900-7783-4cbe-94ea-a546bc88b811 very informative, highly recommend tuning in to the ep!
td, $ACOG.v trading at $1.09 with market cap at $67.03 M
Be the first to comment on this post